What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Thomas J. Polascik spends much of his time researching Prostate cancer, Surgery, Internal medicine, Prostate and Prostatectomy.
His Prostate cancer research is classified as research in Cancer.
The Surgery study combines topics in areas such as Renal cell carcinoma and Cryoablation.
His Internal medicine research is multidisciplinary, incorporating perspectives in Perioperative and Oncology.
His biological study spans a wide range of topics, including Endocrinology and Pathology.
His Prostatectomy research is multidisciplinary, relying on both Survival rate, Gynecology and Radiation therapy.
His most cited work include:
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumours (585 citations)
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING (545 citations)
- Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. (337 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Prostate cancer, Internal medicine, Prostate, Surgery and Prostatectomy.
His work deals with themes such as Biopsy, Radiology and Urology, which intersect with Prostate cancer.
His work focuses on many connections between Urology and other disciplines, such as Proportional hazards model, that overlap with his field of interest in Hazard ratio.
He interconnects Gynecology, Oncology and MEDLINE in the investigation of issues within Internal medicine.
Thomas J. Polascik has researched Prostate in several fields, including Stage and Disease, Pathology.
His Surgery research integrates issues from Renal cell carcinoma, Nephrectomy and Cryoablation.
He most often published in these fields:
- Prostate cancer (67.23%)
- Internal medicine (38.27%)
- Prostate (32.35%)
What were the highlights of his more recent work (between 2017-2021)?
- Prostate cancer (67.23%)
- Internal medicine (38.27%)
- Oncology (22.83%)
In recent papers he was focusing on the following fields of study:
Thomas J. Polascik mainly focuses on Prostate cancer, Internal medicine, Oncology, Prostate and Radiology.
Particularly relevant to Prostatectomy is his body of work in Prostate cancer.
His study on Oncology also encompasses disciplines like
- Castration resistant that connect with fields like Overall survival,
- Urinary retention most often made with reference to Androgen deprivation therapy.
His studies deal with areas such as Interquartile range and Randomized controlled trial as well as Prostate.
His Radiology research is multidisciplinary, relying on both Disease progression, MEDLINE and Multiparametric MRI.
His Cryoablation study incorporates themes from Cryotherapy and Cryosurgery.
Between 2017 and 2021, his most popular works were:
- Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: Experience of the society of abdominal radiology prostate cancer disease-focused panel (39 citations)
- Surveillance after prostate focal therapy. (32 citations)
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 (25 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Prostate cancer, Internal medicine, Oncology, Prostate and Biopsy are his primary areas of study.
His Prostate cancer study introduces a deeper knowledge of Cancer.
His Hazard ratio, Proportional hazards model and Statin study in the realm of Internal medicine connects with subjects such as Glycated hemoglobin.
The Oncology study combines topics in areas such as Castration resistant and Germline mutation.
His study looks at the intersection of Prostate and topics like Radiation therapy with Quartile, Urinary function and Androgen deprivation therapy.
He usually deals with Biopsy and limits it to topics linked to Prostate biopsy and Ultrasound, Prostate-specific antigen, Cutoff point and Urology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
